Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response
Year: 2018
Type: article
Study design: Observational Study
Source: Neuron
Institutions: University of Miami, Emory University
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funders: Brain and Behavior Research Foundation, American Foundation for Suicide Prevention, Eli Lilly and Company, Hope for Depression Research Foundation, ACADIA Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, National Institutes of Health, Laureate Institute for Brain Research, University of Tulsa, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Janssen Pharmaceuticals
Awards: G1042345549, Th17 cells as a new therapeutic target for depression, The microbiota, a possible link between Th17 cells and depression, Neural Correlates of Loss Aversion in Major Depression, Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity, Predictors of Treatment Response Relapse and Recurrence in Major Depression, Predictors of Antidepressant Treatment Response: The Emory CIDAR
OpenAlex ID: W2888411058
